4//SEC Filing
Boston Megan 4
Accession 0001062993-24-020462
CIK 0001808898other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:17 PM ET
Size
5.1 KB
Accession
0001062993-24-020462
Insider Transaction Report
Form 4
Boston Megan
DirectorChief Financial Officer
Transactions
- Award
Options (right to buy)
2024-12-09+720,000→ 720,000 totalExercise: $12.18Exp: 2034-12-09→ Common Stock (720,000 underlying)
Footnotes (1)
- [F1]The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025.
Issuer
Benitec Biopharma Inc.
CIK 0001808898
Entity typeother
Related Parties
1- filerCIK 0001808923
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:17 PM ET
- Size
- 5.1 KB